Glatopa 40 mg/mL (Glatiramer Acetate INJECTION, SOLUTION) 40 mg/mL

Glatopa 40 mg/mL is a subcutaneous injection solution containing glatiramer acetate. It is commonly used for managing specific neurological conditions. This medication is designed to support treatment regimens as prescribed by healthcare professionals.

Strength

40 mg/mL

Pack Size

12 BLISTER PACK in 1 CARTON (0781-3250-89) / 1 SYRINGE, GLASS in 1 BLISTER PACK / 1 mL in 1 SYRINGE

Manufacturer / TM Owner

Sandoz Inc

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Glatopa 40 mg/mL is primarily used for the management of relapsing forms of multiple sclerosis. This medication works by modulating the immune system to reduce the frequency of relapses. Patients often wonder, 'What is Glatopa used for?' It is typically prescribed to help manage symptoms and slow the progression of the disease.

Side Effects

Common effects of Glatopa 40 mg/mL may include redness, pain, or swelling at the injection site. Some users might experience flu-like symptoms, such as fever, chills, or fatigue. These effects are generally mild and temporary, but any persistent or severe reactions should be discussed with a healthcare provider.

Precautions & Warnings

Glatopa 40 mg/mL should be stored at room temperature and protected from light. It is important to follow proper injection techniques to minimize the risk of infection. Patients should be aware of potential allergic reactions and seek immediate medical attention if severe symptoms occur.

Avoid Interactions

Glatopa 40 mg/mL may interact with other medications, including those that affect the immune system. It is advisable to inform healthcare providers about all current medications to avoid potential interactions. Alcohol and certain supplements may also influence the effectiveness of this treatment.

References

Frequently Asked Questions

Glatopa 40 mg/mL is used to manage relapsing forms of multiple sclerosis by modulating the immune system.

Glatopa 40 mg/mL is administered via subcutaneous injection, typically into the thigh, abdomen, or upper arm.

Common side effects include redness, pain, or swelling at the injection site, as well as flu-like symptoms.

Glatopa 40 mg/mL may interact with other medications, so it is important to consult a healthcare provider before combining treatments.

Glatopa 40 mg/mL should be stored at room temperature and protected from light to maintain its effectiveness.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.